Carcinoma testicular de células germinales no seminomatoso estadio I, supervivencia global en pacientes posterior a tratamiento primario
Testicular non-seminomatous germ cell carcinoma stage I, overall survival in patients following primary treatment

urol. colomb. (Bogotá. En línea); 33 (3), 2024
Publication year: 2024

Objetivo:

Caracterizar la supervivencia global (SG) y la supervivencia libre de recurrencia (SLR) de pacientes con carcinoma testicular de células germinales no seminomatoso (NSGCT) estadio I derivados a diferentes opciones de adyuvancia.

Método:

Búsqueda de pacientes con NSGCT estadio I llevados a orquiectomía radical del 2010-2022. La descripción se hizo con medidas de tendencia central.

Resultados:

En el modelo de regresión no hubo diferencias.

Conclusiones:

No se encontraron diferencias en SG o SLR. Se requieren estudios prospectivos para corroborar hallazgos

Objective:

To characterize overall survival (OS) and recurrence-free survival (RFS) in patients with stage I testicular non-seminomatous germ cell carcinoma (NSGCT) referred to different adjuvant treatment options.

Method:

Patient search included individuals with stage I NSGCT who underwent radical orchiectomy from 2010 to 2022. The statistical description was conducted using measures of central tendency.

Results:

In the regression model, no differences were observed.

Conclusions:

No differences were found in OS or RFS. Prospective studies are needed to confirm these findings

More related